The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.
NYS Entity Status
NYS Filing Date
AUGUST 14, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - AMERICA HARVARD IVF MANAGEMENT CORP
AROUND THE WEB
- Considering the Side Effects of Drugmakers’ Money-Back Guarantees
By KATIE THOMAS and CHARLES ORNSTEIN - Monday Jul 10, 2017
- Marine Corps Plane Crash: The Victims
By THE NEW YORK TIMES - Thursday Jul 13, 2017
Family members and friends have begun identifying many of the 16 American service members who died on Monday when their plane crashed in rural Mississippi.
- Could the Rockaways Survive Another Sandy?
By LUIS FERRÉ-SADURNÍ - Thursday Jul 13, 2017
Residents are bracing for the worst, wondering whether measures taken so far are enough to keep devastation of the Queens community at bay.
- Slow. Small. Simple
Friday Apr 7, 2017
Why the keys to innovation, creativity, and self-actualization lie in how we think.
- SF’s Invitae to acquire two prenatal genetic screening firms
By Catherine Ho - Monday Jul 31, 2017
The two acquired firms — Good Start Genetics of Cambridge, Mass., and Irvine’s CombiMatrix — specialize in testing pregnant women and fetuses for genetic abnormalities that may increase the likelihood of developmental problems in the child.The tests are ordered by obstetricians and reproductive endocrinologists for patients undergoing in vitro fertilization, or IVF.Several other firms already compete in the prenatal genetic screening market, including South San Francisco’s Counsyl, San Carlos’ Natera and San Diego’s Sequenom, which is owned by the lab diagnostics giant LabCorp.Prenatal screening has become more widely available in recent years, as the technology to screen for genetic abnormalities continues to advance rapidly.[...] some experts have cautioned against interpreting the results — which can yield false positives — without seeking the advice of a medical expert or genetic counselor.Unlike direct-to-consumer genetic tests like those sold by 23andMe, these tests are ordered by a physician and increasingly are covered by major commercial health insurers.Invitae currently partners with biotech firms MyoKardia, BioMarin and Alnylam Pharmaceuticals to share patients’ genetic information, with their consent, to be used in the development of drugs to treat genetic disorders, including patients’ participation in clinical trials.
- One-fifth of Americans find workplace hostile or threatening
By Paul Wiseman - Monday Aug 14, 2017
One-fifth of Americans find workplace hostile or threatening[...] concludes an in-depth study of 3,066 U.S. workers by the Rand Corp., Harvard Medical School and UCLA.Nearly 1 in 5 workers — a share the study calls “disturbingly high” — say they face a hostile or threatening environment at work, which can include sexual harassment and bullying.Workers who have to face customers endure a disproportionate share of abuse.“I was surprised at how physically demanding jobs were,” says lead author Nicole Maestas, a Harvard Medical School economist.The unemployment rate is at a 16-year low, and many employers complain they can’t fill jobs.More than 80 percent say they get to solve problems and try out their own ideas.[...] 58 percent say their bosses are supportive, and 56 percent say they have good friends at work.